|
APOLD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.87609999652483E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.56630000000591E-05 |
| Normal-vs-Stage2 |
3.779700E-04 |
| Normal-vs-Stage3 |
1.52329999999479E-05 |
| Normal-vs-Stage4 |
1.84459999996722E-06 |
| Stage1-vs-Stage2 |
7.133400E-01 |
| Stage1-vs-Stage3 |
7.137200E-01 |
| Stage1-vs-Stage4 |
7.229600E-01 |
| Stage2-vs-Stage3 |
9.059800E-01 |
| Stage2-vs-Stage4 |
4.988800E-01 |
| Stage3-vs-Stage4 |
4.585600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.41700000020084E-07 |
| Normal-vs-AfricanAmerican |
1.248350E-02 |
| Normal-vs-Asian |
2.33119999970555E-07 |
| Caucasian-vs-AfricanAmerican |
2.203600E-01 |
| Caucasian-vs-Asian |
3.276200E-01 |
| AfricanAmerican-vs-Asian |
1.359840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.90899999983085E-07 |
| Normal-vs-Female |
1.639870E-03 |
| Male-vs-Female |
2.514200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.007990E-04 |
| Normal-vs-Extreme_Weight |
2.1036999997559E-07 |
| Normal-vs-Obese |
1.46540000001139E-06 |
| Normal-vs-Extreme_Obese |
5.13550000302843E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.241200E-01 |
| Normal_Weight-vs-Obese |
4.785400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.580000E-02 |
| Extreme_Weight-vs-Obese |
5.975500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.079700E-02 |
| Obese-vs-Extreme_Obese |
2.635600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.864200E-03 |
| Normal-vs-Age(41-60Yrs) |
8.88590000025502E-07 |
| Normal-vs-Age(61-80Yrs) |
7.80479999999972E-05 |
| Normal-vs-Age(81-100Yrs) |
6.64760000379516E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.482000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.171600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.547700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.050800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.086400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.739700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.42169999994834E-07 |
| Normal-VS-Type2 PRCC |
2.79410000003644E-06 |
| Normal-VS-KIRP CIMP |
1.574160E-01 |
| Normal-VS-Unclassified PRCC |
1.2285999995143E-07 |
| Type1 PRCC-VS-Type2 PRCC |
6.844500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.639700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.647600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.598500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.375100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.393900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.60640000044377E-07 |
| Normal-vs-N1 |
1.1030000000023E-06 |
| Normal-vs-N2 |
1.364170E-01 |
| N0-vs-N1 |
7.531000E-01 |
| N0-vs-N2 |
3.243000E-01 |
| N1-vs-N2 |
1.341440E-01 |
|
|
